ÖÐÎÄÃû³Æ£º Íÿ¹PRKAR2B(Ab-113) ¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-PRKAR2B(Ab-113) rabbit polyclonal antibody
±ð Ãû£º PRKAR2; RII-BETA
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â
¿¹ Ô£º PRKAR2B(Ab-113)
ËÞ Ö÷£º Rabbit
·´Ó¦ÖÖÊô£º Human Mouse Rat
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
PRKAR2B(Ab-113) |
|
Immunogen: |
Synthesized non-phosphopeptide derived from human PKA-R2¦Â around the phosphorylation site of serine 113 (R-A-S(p)-V-C). |
|
Full name: |
protein kinase, cAMP-dependent, regulatory, type II, beta |
|
Synonyms£º |
PRKAR2; RII-BETA |
|
SwissProt: |
P31323 |
|
IHC positive control: |
Human colon carcinoma tissue |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
46 kDa |
|
WB Positive control: |
HepG2 cells and K562 cells lysates |
|
WB Recommended dilution: |
500-3000 |


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
